These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24858204)

  • 1. Dynamics of interleukin-21 production during the clinical course of primary and secondary dengue virus infections.
    Vivanco-Cid H; Maldonado-Rentería MJ; Sánchez-Vargas LA; Izaguirre-Hernández IY; Hernández-Flores KG; Remes-Ruiz R
    Immunol Lett; 2014 Sep; 161(1):89-95. PubMed ID: 24858204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever.
    Bachal R; Alagarasu K; Singh A; Salunke A; Shah P; Cecilia D
    Arch Virol; 2015 Oct; 160(10):2435-43. PubMed ID: 26175069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar.
    Ngwe Tun MM; Thant KZ; Inoue S; Kurosawa Y; Lwin YY; Lin S; Aye KT; Thet Khin P; Myint T; Htwe K; Mapua CA; Natividad FF; Hirayama K; Morita K
    J Med Virol; 2013 Jul; 85(7):1258-66. PubMed ID: 23595687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G (IgG) to IgM ratio in secondary adult dengue infection using samples from early days of symptoms onset.
    Cucunawangsih ; Lugito NP; Kurniawan A
    BMC Infect Dis; 2015 Jul; 15():276. PubMed ID: 26193930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dengue virus infections in a sample of patients suggests unique clinical, immunological, and virological profiles that impact on the diagnosis of dengue and dengue hemorrhagic fever.
    Senaratne T; Wimalaratne H; Alahakoon DG; Gunawardane N; Carr J; Noordeen F
    J Med Virol; 2016 Oct; 88(10):1703-10. PubMed ID: 26990973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections.
    Vázquez S; Cabezas S; Pérez AB; Pupo M; Ruiz D; Calzada N; Bernardo L; Castro O; González D; Serrano T; Sanchez A; Guzmán MG
    Int J Infect Dis; 2007 May; 11(3):256-62. PubMed ID: 16914345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
    Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
    Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
    Lau L; Green AM; Balmaseda A; Harris E
    J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential clinical symptoms among acute phase Indian patients revealed significant association with dengue viral load and serum IFN-gamma level.
    Pal T; Dutta SK; Mandal S; Saha B; Tripathi A
    J Clin Virol; 2014 Nov; 61(3):365-70. PubMed ID: 25288310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
    Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
    J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a dengue patient cohort in Recife, Brazil.
    Cordeiro MT; Silva AM; Brito CA; Nascimento EJ; Magalhães MC; Guimarães GF; Lucena-Silva N; de Carvalho EM; Marques ET
    Am J Trop Med Hyg; 2007 Dec; 77(6):1128-34. PubMed ID: 18165535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue.
    Levy A; Valero N; Espina LM; Añez G; Arias J; Mosquera J
    Trans R Soc Trop Med Hyg; 2010 Jan; 104(1):16-23. PubMed ID: 19733377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of antibody biomarkers of long term and recent dengue virus infections.
    Nascimento EJM; Huleatt JW; Cordeiro MT; Castanha PMS; George JK; Grebe E; Welte A; Brown M; Burke DS; Marques ETA
    J Virol Methods; 2018 Jul; 257():62-68. PubMed ID: 29684416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indices of anti-dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase.
    Posadas-Mondragón A; Aguilar-Faisal JL; Chávez-Negrete A; Guillén-Salomón E; Alcántara-Farfán V; Luna-Rojas L; Ávila-Trejo AM; Del Carmen Pacheco-Yépez J
    Microbiol Immunol; 2017 Oct; 61(10):433-441. PubMed ID: 28881485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.
    Puschnik A; Lau L; Cromwell EA; Balmaseda A; Zompi S; Harris E
    PLoS Negl Trop Dis; 2013; 7(6):e2274. PubMed ID: 23785536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on dengue and dengue haemorrhagic fever (DHF) in West Bengal State, India.
    Hati AK
    J Commun Dis; 2006 Mar; 38(2):124-9. PubMed ID: 17370674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological markers during dengue 3 primary and secondary infections.
    Vázquez S; Pérez AB; Ruiz D; Rodríguez R; Pupo M; Calzada N; González L; González D; Castro O; Serrano T; Guzmán MG
    J Clin Virol; 2005 Jun; 33(2):132-7. PubMed ID: 15911428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin G antibody response in children and adults with acute dengue 3 infection.
    Vazquez S; Acosta N; Ruiz D; Calzada N; Alvarez AM; Guzman MG
    J Virol Methods; 2009 Jul; 159(1):6-9. PubMed ID: 19442837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered profile of regulatory T cells and associated cytokines in mild and moderate dengue.
    Tillu H; Tripathy AS; Reshmi PV; Cecilia D
    Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):453-61. PubMed ID: 26861813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.